9573736

Source:http://linkedlifedata.com/resource/pubmed/id/9573736

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0205547, umls-concept:C0850666
pubmed:issue	1
pubmed:dateCreated	1998-6-2
pubmed:abstractText	Ulcer patients need to be treated for Helicobacter pylori infection. Seven days of quadruple therapy achieves the highest cure rates. In this study a 4-day quadruple regimen of lansoprazole, bismuth, tetracycline and metronidazole is investigated.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0356133
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo..., http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Metronidazole, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole, http://linkedlifedata.com/resource/pubmed/chemical/Organometallic Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Tetracycline, http://linkedlifedata.com/resource/pubmed/chemical/bismuth tripotassium dicitrate, http://linkedlifedata.com/resource/pubmed/chemical/lansoprazole
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0300-2977
pubmed:author	pubmed-author:SchneebergerP MPM, pubmed-author:de BoerW AWA, pubmed-author:van EttenR JRJ
pubmed:issnType	Print
pubmed:volume	52
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	10-5
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9573736-2-Pyridinylmethylsulfinylbenzimidazoles, pubmed-meshheading:9573736-Adult, pubmed-meshheading:9573736-Aged, pubmed-meshheading:9573736-Anti-Bacterial Agents, pubmed-meshheading:9573736-Drug Administration Schedule, pubmed-meshheading:9573736-Drug Resistance, Microbial, pubmed-meshheading:9573736-Drug Therapy, Combination, pubmed-meshheading:9573736-Dyspepsia, pubmed-meshheading:9573736-Female, pubmed-meshheading:9573736-Gastroscopy, pubmed-meshheading:9573736-Helicobacter Infections, pubmed-meshheading:9573736-Helicobacter pylori, pubmed-meshheading:9573736-Humans, pubmed-meshheading:9573736-Male, pubmed-meshheading:9573736-Metronidazole, pubmed-meshheading:9573736-Microbial Sensitivity Tests, pubmed-meshheading:9573736-Middle Aged, pubmed-meshheading:9573736-Netherlands, pubmed-meshheading:9573736-Omeprazole, pubmed-meshheading:9573736-Organometallic Compounds, pubmed-meshheading:9573736-Tetracycline, pubmed-meshheading:9573736-Treatment Outcome
pubmed:year	1998
pubmed:articleTitle	Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection.
pubmed:affiliation	Department of Internal Medicine, Sint Anna Ziekenhuis, Oss, Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial